We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
2876
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-5,468
Closed -$86.2K
VLD
2877
DELISTED
Velo3D, Inc.
VLD
-1,152
Closed -$62.9K
TWOU
2878
DELISTED
2U Inc
TWOU
-1,316
Closed -$97.5K
LICY
2879
DELISTED
Li-Cycle Holdings Corp.
LICY
-8,888
Closed -$252K
RPT
2880
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-44,784
Closed -$473K
PNT
2881
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-46,389
Closed -$309K
SGEN
2882
DELISTED
Seagen Inc. Common Stock
SGEN
-8,617
Closed -$1.83M
VRTV
2883
DELISTED
VERITIV CORPORATION
VRTV
-6,871
Closed -$1.16M
PACW
2884
DELISTED
PacWest Bancorp
PACW
-63,526
Closed -$502K
HT
2885
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-16,848
Closed -$166K
AVTA
2886
DELISTED
Avantax, Inc. Common Stock
AVTA
-20,779
Closed -$532K
VMW
2887
DELISTED
VMware, Inc
VMW
-13,231
Closed -$2.2M
SCU
2888
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-12,461
Closed -$145K
ARGO
2889
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-16,963
Closed -$506K
CCF
2890
DELISTED
Chase Corporation
CCF
-4,003
Closed -$509K
EQRX
2891
DELISTED
EQRx, Inc. Common Stock
EQRX
-171,551
Closed -$381K
NXGN
2892
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-29,134
Closed -$691K
NEWR
2893
DELISTED
New Relic, Inc.
NEWR
-3,449
Closed -$295K
ICPT
2894
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-21,600
Closed -$400K
TWNK
2895
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-69,349
Closed -$2.31M
AVID
2896
DELISTED
Avid Technology Inc
AVID
-17,091
Closed -$459K
DEN
2897
DELISTED
Denbury Inc.
DEN
-26,736
Closed -$2.62M
FRGI
2898
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-9,487
Closed -$80.3K
CIR
2899
DELISTED
CIRCOR International, Inc
CIR
-10,683
Closed -$596K
HCCI
2900
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-9,280
Closed -$421K

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.